Through the application of the advancing technology of pattern recognition, this new SVM-based system is intended to further improve the sensitivity of the Pap test and augment the recent improvements in computer guided screening that have already significantly improved detection rates.
In addition, images and interpretative data from this new SVM-based system may now be transmitted electronically, thus allowing remote review and collaborative interpretation. Early detection using advanced screening technologies provides the best chance for effective, minimally invasive treatment before abnormal cell changes progress to advanced cancer.
Stephen Barnhill, chairman and CEO of Health Discovery, said: “We are very excited to be working with DCL’s state-of-the-art clinical laboratory and their expert cytopathologists in the development of what could be the world’s first SVM-based computer assisted diagnostic (CAD) system available to improve the sensitivity of screening for cervical cancer.”